Celularity (CELU) Stock: Buy, Sell, or Hold?
CELU - Celularity Inc. Class A Common Stock
$0.82
0.02 (2.17%)
▲
5d:
+3.76%
30d:
-52.05%
90d:
+11.67%
HOLD
LOW Confidence
Analysis Updated: Nov 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
9d
Get Alerted When CELU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CELU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CELU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CELU is currently trading at $0.82, which is considered oversold relative to its 30-day fair value range of $0.94 to $1.51.
Technical Outlook: Technically, CELU is in a uptrend. Immediate support is located at $0.66, while resistance sits at $1.31.
Market Sentiment: CELU scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $2.50 (+211.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CELU is in a uptrend. Immediate support is located at $0.66, while resistance sits at $1.31.
Market Sentiment: CELU scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $2.50 (+211.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.94 -
$1.51
Company Quality Score
58/100
(HOLD)
Options IV Signal
100th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
75.0%
Protect Your Profits
Holding CELU? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 100th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 211.5% below Wall St target ($2.50)
- CAUTION: Bottoming setup, but lagging the sector by 31% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.94 -
$1.51
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.56
(68.4%)
Support & Resistance Levels
Support Level
$0.66
Resistance Level
$1.31
Current Trend
Uptrend
Technical data as of
Nov 2, 2026
Fundamental Context
Wall Street Target
$2.50
(+211.5%)
Revenue Growth (YoY)
-5.3%
Earnings Growth (YoY)
-61.3%
Profit Margin
-245.7%
Share & Embed Analysis
Last updated: November 03, 2026 11:08 AM ET
Data refreshes hourly during market hours. Next update: 12:08 PM
Data refreshes hourly during market hours. Next update: 12:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$259 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 44 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 52 HOLD |
Advanced CELU Option Strategies
Professional options setups generated by AI based on today's CELU price and gamma walls.
